Lenalidomide (Revlimid ) Lenalidomide is approved for treating lower-risk transfusion-dependent MDS in patients with isolated deletion 5q whether or not tests show they have other abnormal chromosomes. It may also be used to help other patients with MDS. It is a capsule you take by mouth and it can be taken at home.